ArticleJournal of neuroinflammation2026

CNS-targeted NLRP3 Inhibition by NT-0527 confers therapeutic advantage in a CAPS mouse model.

Beverly H Koller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.